SCHEMBL4079910

SCHEMBL4079910

O=C(O)c1cccc(C2COCO2)c1

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PARP1 P09874 1/20 0.58
KMO O15229 3/20 0.50
CA12 O43570 1/20 0.41
CA1 P00915 1/20 0.41
CA2 P00918 1/20 0.41
CA6 P23280 1/20 0.41
CA9 Q16790 1/20 0.41
TSHR P16473 1/20 0.40
ALDH1A1 P00352 4/20 0.40
KMT2A Q03164 3/20 0.39
KDM4E B2RXH2 2/20 0.39
MEN1 O00255 2/20 0.39
GAA P10253 2/20 0.39
HPGD P15428 2/20 0.39
HSD17B10 Q99714 2/20 0.39
CYP1A2 P05177 1/20 0.39
CYP2C9 P11712 1/20 0.39
UNG P13051 1/20 0.38
LMNA P02545 1/20 0.37
MAPT P10636 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4274420 0.89 PARP1 (0.72) PARP1KMOCA12CA1CA2
SCHEMBL14997104 0.86 PARP1 (0.56) PARP1KMOCA12CA1CA2
SCHEMBL7999629 0.85 PARP1 (0.55) PARP1KMOCA12CA1CA2
Phenol SCHEMBL28650467 0.81 PARP1 (0.62) PARP1KMOCA12CA1CA2
Aniline SCHEMBL28655458 0.80 PARP1 (0.65) PARP1KMOCA12CA1CA2
SCHEMBL1556706 0.77 DRD3 (0.51) PARP1CA12CA2CA9TSHR
SCHEMBL18907044 0.77 KMO (0.65) PARP1KMOCA12CA1CA2
SCHEMBL528466 0.75 TSHR (0.70) TSHRKMT2AMEN1
SCHEMBL1499340 0.73 PARP1 (0.70) PARP1KMOTSHRALDH1A1KMT2A
SCHEMBL30004753 0.73 PARP1 (1.00) PARP1TSHRHSD17B10MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2044004-A2 BENZAMIDE DERIVATIVES AS MODULATORS OF 11BETA-HSD1 FOR TREATING DIABETES AND OBESITY Amgen Inc. (US) 2009-04-08 EP disclosed
WO-2007145835-A2 BENZAMIDE DERIVATIVES AS MODULATORS OF 11BETA-HSD1 FOR TREATING DIABETES AND OBESITY AMGEN INC. (US) 2007-12-21 WO disclosed